prikaz prve stranice dokumenta Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
Rad nije dostupan
Znanstveni rad - Pismo
Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
Annals of Hematology, 102 (2023), 9; 2633-2634. https://doi.org/10.1007/s00277-023-05335-x
Tomulić Brusich, Katarina; Juričić, Kazimir; Bobinac, Mirna; Milošević, Marko; Protić, Alen; Boban, Ana

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Tomulić Brusich, K., Juričić, K., Bobinac, M., Milošević, M., Protić, A. i Boban, A. (2023). Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome. Annals of Hematology, 102. (9), 2633-2634. doi: 10.1007/s00277-023-05335-x

Tomulić Brusich, Katarina, et al. "Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome." Annals of Hematology, vol. 102, br. 9, 2023, str. 2633-2634. https://doi.org/10.1007/s00277-023-05335-x

Tomulić Brusich, Katarina, Kazimir Juričić, Mirna Bobinac, Marko Milošević, Alen Protić i Ana Boban. "Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome." Annals of Hematology 102, br. 9 (2023): 2633-2634. https://doi.org/10.1007/s00277-023-05335-x

Tomulić Brusich, K., et al. (2023) 'Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome', Annals of Hematology, 102(9), str. 2633-2634. doi: 10.1007/s00277-023-05335-x

Tomulić Brusich K, Juričić K, Bobinac M, Milošević M, Protić A, Boban A. Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome. Annals of Hematology [Internet]. 26.06.2023. [pristupljeno 09.05.2024.];102(9):2633-2634. doi: 10.1007/s00277-023-05335-x

K. Tomulić Brusich, K. Juričić, M. Bobinac, M. Milošević, A. Protić i A. Boban, "Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome", Annals of Hematology, vol. 102, br. 9, str. 2633-2634, Lipanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:497704. [Citirano: 09.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:497704
Podaci o radu
Naslov (engleski)Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
AutorKatarina Tomulić Brusich
AutorKazimir Juričić
AutorMirna Bobinac
AutorMarko Milošević
AutorAlen Protić
AutorAna Boban
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za anesteziologiju, reanimatologiju, hitnu i intenzivnu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Anesteziologija i reanimatologija
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pismo
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaAnnals of Hematology
Brojčani podacivol. 102, br. 9, str. 2633-2634
p-ISSN0939-5555
e-ISSN1432-0584
DOIhttps://doi.org/10.1007/s00277-023-05335-x
URN:NBNurn:nbn:hr:184:497704
Datum objave publikacije2023-06-26
URL dokumentahttps://link.springer.com/10.1007/s00277-023-05335-x
Vrsta resursaTekst
Prava pristupaZatvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2023-11-13 13:38:37